Board of Alembic Pharmaceuticals approves private placement of NCDs up to Rs 500 crore

At meeting held on 06 December 2018

The Board of Directors of Alembic Pharmaceuticals at its meeting held on 06 December 2018 has inter-alia (i) approved the Issue of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 500 crore on Private Placement Basis under a shelf disclosure document in multiple tranches and (ii) Constituted NCD Committee for issue and allotment of NCDs.

Powered by Capital Market - Live News